Bell's palsy and SARS-CoV-2 vaccines.

Ozonoff, Al; Nanishi, Etsuro; Levy, Ofer

Ozonoff, Al; Nanishi, Etsuro; Levy, Ofer.

Ozonoff A; Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA.
Nanishi E; Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
Levy O; Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA. Electronic address: ofer.levy@childrens.harvard.edu.

Lancet Infect Dis ; 21(4): 450-452, 2021 04.

Article in English | MEDLINE | ID: covidwho-1189081

Subject(s)

Bell Palsy/etiology; COVID-19 Vaccines/adverse effects; Bell Palsy/epidemiology; COVID-19/epidemiology; COVID-19/immunology; COVID-19/prevention & control; Humans; Influenza Vaccines/adverse effects; SARS-CoV-2/immunology; SARS-CoV-2/isolation & purification; United States/epidemiology; United States Food and Drug Administration

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Bell Palsy / COVID-19 Vaccines Type of study: Observational study Topics: Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: S1473-3099(21)00076-1

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google